Methylphenidate-osmotic-controlled release oral delivery system treatment reduces parenting stress in parents of children and adolescents with attention-deficit/hyperactivity disorder

Title
Methylphenidate-osmotic-controlled release oral delivery system treatment reduces parenting stress in parents of children and adolescents with attention-deficit/hyperactivity disorder
Author(s)
서완석황준원[황준원]김봉석[김봉석]김예니[김예니]김태호[김태호]신동원[신동원]우영재[우영재]유희정[유희정]이정섭[이정섭]이종훈[이종훈]임명호[임명호]정영철[정영철]정철호[정철호]유한익[유한익]
Keywords
DEFICIT HYPERACTIVITY DISORDER; MATERNAL DEPRESSION; BEHAVIOR PROBLEMS; ADHD; FAMILIES; INVENTORY; ADHERENCE; DIAGNOSIS; SEVERITY; MOTHERS
Issue Date
201311
Publisher
WILEY-BLACKWELL
Citation
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, v.28, no.6, pp.600 - 607
Abstract
ObjectiveThe aim of the current study was to investigate the effect of methylphenidate-osmotic release oral delivery system (MPH-OROS) treatment on parenting stress in parents of children and adolescents with attention-deficit/hyperactivity disorder (ADHD). MethodsFour hundred and ninety-five children and adolescents (391 boys and 104 girls), aged 7 to 18years who met the Diagnostic and Statistical Manual of Mental Disorders, fourth edition criteria for ADHD, were recruited at 48 psychiatric outpatient clinics across South Korea. Children's symptoms, parenting stress, and parental depression were assessed at baseline, week 4, and week 8 of MPH-OROS treatment using the Korean version of the DuPaul's ADHD Rating Scale (ARS), the Beck's Depression Inventory (BDI), and the Parenting Stress Index, Short Form (PSI-SF). ResultsWe found significantly decreased scores of ARS, parental BDI, and PSI-SF from baseline to week 4 and from week 4 to week 8. Also, there were positive correlations among baseline PSI-SF, ARS, and BDI scores. The changes in BDI and ARS scores were significantly associated with the PSI score changes, accounting for 20.1% and 10.0%, respectively. ConclusionsWe suggest that the increased parenting stress and depression in parents of children and adolescents with ADHD can be improved following the treatment with MPH-OROS. Copyright (c) 2013 John Wiley & Sons, Ltd.
URI
http://hdl.handle.net/YU.REPOSITORY/28498http://dx.doi.org/10.1002/hup.2363
ISSN
0885-6222
Appears in Collections:
의과대학 > 정신건강의학교실 > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE